These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25818995)

  • 1. The utility of thromboelastometry in prophylactic platelet transfusion for hematological malignancies.
    Akay OM; Goren Sahin D; Andic N; Gunduz E; Karagulle M; Colak E; Gulbas Z
    Transfus Apher Sci; 2015 Aug; 53(1):64-8. PubMed ID: 25818995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of platelet transfusions evaluated using rotational thromboelastometry.
    Flisberg P; Rundgren M; Engström M
    Anesth Analg; 2009 May; 108(5):1430-2. PubMed ID: 19372316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
    Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
    Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of bleeding and transfusion during liver transplantation before and after the introduction of a rotational thromboelastometry-based algorithm.
    Roullet S; Freyburger G; Cruc M; Quinart A; Stecken L; Audy M; Chiche L; Sztark F
    Liver Transpl; 2015 Feb; 21(2):169-79. PubMed ID: 25331016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet transfusions for patients with haematological malignancies: who needs them?
    Estcourt LJ; Stanworth SJ; Murphy MF
    Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry.
    Kander T; Tanaka KA; Norström E; Persson J; Schött U
    Anesth Analg; 2014 Oct; 119(4):882-890. PubMed ID: 24854870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.
    Tripodi A; Primignani M; Chantarangkul V; Lemma L; Jovani M; Rebulla P; Mannucci PM
    Liver Int; 2013 Mar; 33(3):362-7. PubMed ID: 23231699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests.
    Coakley M; Reddy K; Mackie I; Mallett S
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):548-53. PubMed ID: 16884987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with prophylactic platelet transfusion trigger in haematological patients.
    Eikenboom JC; van Wordragen R; Brand A
    Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies.
    Gatt A; Bonello F; Buttigieg R; Debono S; Brincat P; Grima C; Gatt P; Lofaro T; Laspina S
    Blood Transfus; 2014 Oct; 12(4):479-84. PubMed ID: 24960660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
    Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.
    Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Kiwanuka N; Wald A
    PLoS One; 2019; 14(2):e0211648. PubMed ID: 30726290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
    Sandler SG
    Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and quality evaluation of apheresis vs random-donor platelet concentrates stored for 7 days.
    Hussein E
    Transfus Med; 2015 Feb; 25(1):20-6. PubMed ID: 25808050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.
    Stanworth SJ; Hudson CL; Estcourt LJ; Johnson RJ; Wood EM;
    Haematologica; 2015 Jun; 100(6):740-7. PubMed ID: 25795717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of platelet transfusion.
    McCullough J
    Semin Hematol; 2010 Jul; 47(3):235-42. PubMed ID: 20620434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
    Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.